Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Ivacaftor cost?

See the DrugPatentWatch profile for Ivacaftor

How much does ivacaftor cost in the US?

Ivacaftor (a CFTR modulator used for cystic fibrosis) is typically priced as a brand prescription drug, so the out-of-pocket price can vary a lot depending on insurance coverage, pharmacy pricing, and whether you qualify for manufacturer or government assistance programs. Exact costs aren’t provided here, so the only reliable way to know your price is to check your specific plan or pharmacy quote.

What affects out-of-pocket cost (copay/coinsurance/deductible)?

Your final cost depends on several factors that change from person to person:
- Insurance type and formulary status (tier placement, prior authorization requirements)
- Whether ivacaftor is covered for your specific mutation and treatment indication
- Your deductible status for the year
- Whether you pay a fixed copay or a percentage coinsurance
- Pharmacy (in-network vs out-of-network) and local negotiated prices

Are there patient assistance programs that lower the price?

Many expensive specialty drugs, including CF medicines, have manufacturer support and third-party programs that can reduce costs for eligible patients. Eligibility usually depends on insurance status, income, and residency, and programs often require enrollment or renewal.

If you tell me your country and whether you have commercial insurance, Medicare, Medicaid, or none, I can point you to the most relevant options to check next.

Are there cheaper alternatives if ivacaftor is too expensive?

Sometimes the monthly cost is lower with alternative CFTR modulator regimens if they fit your genotype and clinical plan. Whether that’s possible depends on your CF mutation and what your clinician is targeting.

Can generic versions reduce the cost?

Ivacaftor’s availability as a generic or biosimilar depends on patent and market exclusivity in your country. If a generic exists where you live, switching (with prescriber approval) can reduce cost, but coverage rules still apply.

What’s the fastest way to get an accurate ivacaftor price?

Ask for:
- The pharmacy’s cash price and your insurance price for your exact dose and quantity
- Whether your plan covers the specific product strength/formulation
- Any prior authorization or step-therapy requirements that could delay coverage

If you share: (1) your country, (2) your insurance type, and (3) the ivacaftor strength (or “once/twice daily”), I can help you narrow down the likely pricing path and the best places to check.



Other Questions About Ivacaftor :

Ivacaftor loss of exclusivity ema? Ivacaftor loss of exclusivity? Ivacaftor price? Ivacaftor? Which are the three drug master file entries for ivacaftor? Ivacaftor generic entry? Ivacaftor generic?

AI-Drug Label Prescribing Information Alignment Report

96
96%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The AI claim accurately matches the FDA label’s indications and the label’s guidance for unknown genotype using an FDA-cleared mutation test with bidirectional sequencing when recommended.


Category Scores

Indication
100
Excellent

Accurate Statements

KALYDECO is indicated for treatment of cystic fibrosis (CF) in patients aged 1 month and older who have at least one mutation in the CFTR gene that is responsive to ivacaftor potentiation.
Label Section 1 INDICATIONS AND USAGE (patients aged 1 month and older; at least one CFTR mutation responsive to ivacaftor potentiation based on clinical and/or in vitro assay data).
Including cases where genotype is unknown, using an FDA-cleared CF mutation test with verification by bidirectional sequencing when recommended.
Label Section 1 INDICATIONS AND USAGE (if genotype unknown: use an FDA-cleared CF mutation test followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use).

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The evaluated AI response makes only label-supported indication/testing statements and does not include dosing, safety, contraindications, or interaction guidance.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Drug Brand Mention Assessment

Branding Score
21
Visibility
30
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

a CFTR modulator used for cystic fibrosis


Core Claims
  • Ivacaftor is typically priced as a brand prescription drug.
  • Out-of-pocket price varies depending on insurance coverage, pharmacy pricing, and assistance programs.
  • Exact costs aren’t provided here, so checking a specific plan or pharmacy quote is the reliable way.
  • Final cost depends on insurance type/formulary, whether it’s covered for your mutation/indication, deductible status, and copay vs coinsurance.
  • Ivacaftor’s availability as a generic or biosimilar depends on patent and market exclusivity in your country.
Differentiators
  • Cost depends on whether it is covered for your specific mutation and treatment indication.
  • Coverage may be affected by pharmacy in-network vs out-of-network negotiated prices and local negotiated prices.
  • Some eligible patients may reduce costs via manufacturer support and third-party programs.

Pricing Perception: Mid Range